Literature DB >> 31239265

Individual- and Area-Level Socioeconomic Inequalities in Esophageal Cancer Survival in Shandong Province, China: A Multilevel Analysis.

Kou Kou1, Peter D Baade2, Michelle Gatton1, Susanna M Cramb2, Jiandong Sun3, Zilong Lu4, Zhentao Fu4, Jie Chu4, Aiqiang Xu4, Xiaolei Guo5.   

Abstract

BACKGROUND: China contributes to almost half of the esophageal cancer cases diagnosed globally each year. However, the prognosis information of this disease in this large population is scarce.
METHODS: Data on a population-based cohort consisting of residents of Shandong Province, China who were diagnosed with esophageal cancer during the period from 2005 to 2014 were analyzed. The cancer-specific survival rates were estimated using Kaplan-Meier analysis. Discrete-time multilevel mixed-effects survival models were used to investigate socioeconomic status (SES) disparities on esophageal cancer survival.
RESULTS: The unadjusted 1-, 3-, and 5-year cause-specific survival rates were 59.6% [95% confidence interval (CI), 59.2%-59.9%], 31.9% (95% CI, 31.5%-32.3%), and 23.6% (95% CI, 23.1%-24.0%), respectively. Patients of blue-collar occupations had higher risk of esophageal cancer-related death than those of white-collar occupations in the first 2 years after diagnosis. Rural patients had higher risk of death than urban patients in the first 3 years after diagnosis. The risks of esophageal cancer-related death among patients living in low/middle/high SES index counties were not different in the first 2 years after diagnosis. However, patients living in high SES index counties had better long-term survival (3-5 years postdiagnosis) than those living in middle or low SES index counties.
CONCLUSIONS: Socioeconomic inequalities in esophageal cancer survival exist in this Chinese population. Higher individual- or area-level SES is associated with better short-term or long-term cancer survival. IMPACT: Elucidation of the relative roles of the SES factors on survival could guide interventions to reduce disparities in the prognosis of esophageal cancer. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31239265     DOI: 10.1158/1055-9965.EPI-19-0203

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER).

Authors:  Marquita W Lewis-Thames; Marvin E Langston; Saira Khan; Yunan Han; Lindsay Fuzzell; Shuai Xu; Justin Xavier Moore
Journal:  JAMA Netw Open       Date:  2022-05-02

2.  Association of Esophageal Cancer Mortality with Municipal Socioeconomic Deprivation Level in Japan, 2013-2017: An Ecological Study Using Nationwide Data.

Authors:  Tasuku Okui; Akie Hirata; Naoki Nakashima
Journal:  Int J Environ Res Public Health       Date:  2022-04-30       Impact factor: 4.614

3.  Occurrence and timely management of problems requiring prompt intervention among Indigenous compared with non-Indigenous Australian palliative care patients: a multijurisdictional cohort study.

Authors:  John A Woods; Judith M Katzenellenbogen; Kevin Murray; Claire E Johnson; Sandra C Thompson
Journal:  BMJ Open       Date:  2021-03-16       Impact factor: 2.692

4.  The association between community-level socioeconomic status and cognitive function among Chinese middle-aged and older adults: a study based on the China Health and Retirement Longitudinal Study (CHARLS).

Authors:  Yan Liu; Zhaorui Liu; Richard Liang; Yanan Luo
Journal:  BMC Geriatr       Date:  2022-03-22       Impact factor: 3.921

5.  Clinicopathological significances of PLOD2, epithelial-mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma.

Authors:  Xiaomeng Gong; Ailian Wang; Wenqing Song
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.